Structure Therapeutics (GPCR) Stock Chart & Stock Price History $28.22 +0.26 (+0.93%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Structure Therapeutics Stock Price Performance 5 Day Performance+4.29%1 Month Performance-0.11%3 Month Performance-24.67%6 Month Performance-22.15%Year-To-Date Performance+4.06%1 Year Performance-29.82% Receive GPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Structure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address GPCR Stock Chart for Friday, January, 24, 2025 GPCR Chart by TradingView Structure Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/24/2025$27.96$28.22+0.93%$28.70$27.90376,109 shs$1.62 billion01/23/2025$27.94$27.96+0.07%$28.51$27.15725,275 shs$1.60 billion01/22/2025$28.34$27.94-1.41%$29.00$27.58943,140 shs$1.60 billion01/21/2025$27.06$28.34+4.73%$28.75$26.87706,264 shs$1.62 billion01/20/2025$27.06$27.06$27.45$26.50846,835 shs$1.55 billion01/17/2025$26.98$27.06+0.30%$27.45$26.50846,835 shs$1.55 billion01/16/2025$26.89$26.98+0.33%$27.44$26.06545,344 shs$1.54 billion01/15/2025$25.38$26.89+5.95%$27.68$25.631.34 million shs$1.54 billion01/14/2025$25.16$25.38+0.87%$25.91$24.101.22 million shs$1.45 billion01/13/2025$25.26$25.16-0.40%$26.45$23.501.24 million shs$1.44 billion Get the Latest News and Ratings for GPCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Structure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/10/2025$27.04$25.26-6.58%$26.91$24.95939,734 shs$1.45 billion01/09/2025$27.04$27.04$27.94$26.30837,138 shs$1.55 billion01/08/2025$27.18$27.04-0.52%$27.94$26.30837,138 shs$1.55 billion01/07/2025$27.50$27.18-1.16%$28.28$27.07509,700 shs$1.56 billion01/06/2025$27.76$27.50-0.94%$28.39$27.05588,076 shs$1.57 billion01/03/2025$28.19$27.76-1.53%$28.87$27.44395,153 shs$1.59 billion01/02/2025$27.12$28.19+3.95%$28.40$26.91559,747 shs$1.61 billion01/01/2025$27.12$27.12$27.30$25.90782,410 shs$1.55 billion12/31/2024$26.63$27.12+1.84%$27.30$25.90782,410 shs$1.55 billion12/30/2024$29.04$26.63-8.30%$28.84$26.03791,474 shs$1.52 billion12/27/2024$29.54$29.04-1.69%$30.44$28.87338,613 shs$1.66 billion12/26/2024$28.25$29.54+4.57%$30.43$28.05782,285 shs$1.69 billion12/25/2024$28.25$28.25$28.89$27.89247,464 shs$1.62 billion12/24/2024$28.58$28.25-1.15%$28.89$27.89247,464 shs$1.62 billion12/23/2024$27.90$28.58+2.44%$29.08$27.78697,100 shs$1.64 billion Related Companies Legend Biotech Stock Price Chart Elanco Animal Health Stock Price Chart Cytokinetics Stock Price Chart Nuvalent Stock Price Chart Grifols Stock Price Chart TG Therapeutics Stock Price Chart Axsome Therapeutics Stock Price Chart Krystal Biotech Stock Price Chart Verona Pharma Stock Price Chart Organon & Co. Stock Price Chart Receive GPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Structure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GPCR) was last updated on 1/24/2025 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredJUST RELEASED: HUGE NEW A.I. TRADEI’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Structure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GPCR Stock Alerts